Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers | Zendy

Caroline D.M. Witjes | Zendy; Wojciech G. Polak | Zendy; Cornelis Verhoef | Zendy; Ferry A.L.M. Eskens | Zendy; Roy S. Dwarkasing | Zendy; Joanne Verheij | Zendy; Robert A. de Man | Zendy; Jan N.M. IJzermans | Zendy

Open Access

Increased Alpha-Fetoprotein Serum Level is Predictive for Survival and Recurrence of Hepatocellular Carcinoma in Non-Cirrhotic Livers

Author(s) -

Caroline D.M. Witjes,

Wojciech G. Polak,

Cornelis Verhoef,

Ferry A.L.M. Eskens,

Roy S. Dwarkasing,

Joanne Verheij,

Robert A. de Man,

Jan N.M. IJzermans

Publication year - 2012

Publication title -

digestive surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.762

H-Index - 69

eISSN - 1421-9983

pISSN - 0253-4886

DOI - 10.1159/000348669

Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , cirrhosis , radiofrequency ablation , alpha fetoprotein , multivariate analysis , survival rate , hepatectomy , carcinoma , surgery , resection , ablation

Hepatocellular carcinoma (HCC) may be diagnosed in the absence of cirrhosis. However, little is known about prognostic factors for the survival of HCC patients with a non-cirrhotic liver in the absence of well-established risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research